Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada

BACKGROUND: Administration of magnesium sulphate (MgSO(4)) to women with imminent preterm birth at <34 weeks is an evidence-based antenatal neuroprotective strategy to prevent cerebral palsy. Although a Society of Obstetricians and Gynaecologists of Canada (SOGC) national guideline with practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Teela, Katherine C., De Silva, Dane A., Chapman, Katie, Synnes, Anne R., Sawchuck, Diane, Basso, Melanie, Liston, Robert M., von Dadelszen, Peter, Magee, Laura A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688933/
https://www.ncbi.nlm.nih.gov/pubmed/26694323
http://dx.doi.org/10.1186/s12884-015-0785-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688933/
https://www.ncbi.nlm.nih.gov/pubmed/26694323
http://dx.doi.org/10.1186/s12884-015-0785-8

Ejemplares similares